Principal Investigator
Cynthia Levy
Enrollment Status
Closed
Clinical Trial ID
Institutional Protocol #
20211146
Clinical Trial Summary
Calliditas Therapeutics Suisse SA - GSN000350, TRANSFORM: A 24-week, Randomized, Placebo-controlled, Double-blind, Phase 2b Trial ofSetanaxib in Patients with Primary Biliary Cholangitis (PBC) and ElevatedLiver Stiffness (Pro00056040)
Phase
Phase II
Funding Agency/Sponsor
Industry
Disease
Other
Contact Information
Study Contact
Sonia Carvalho
Phone Number
+1 (305) 2434639
Email
scarvalho@miami.edu